CEACAM5 and colorectal cancer: In the study reported by Wanebo et al,9 stage III colorectal cancer patients with preoperative CEA levels <5 ng/mL showed a longer median disease-free survival (DFS) time compared with those with CEA levels >5 ng/mL (28 months vs. 13 months).